This study aims to evaluate the effects of food or ethnicity on the pharmacokinetics and safety/tolerability of JPI-547 after a single oral administration in healthy male Korean, Caucasian, and Chinese participants.
Healthy Korean, Caucasian, or Chinese male participants aged 19 to 50 years at screening
Body weight between 50.0 and 90.0 kg and BMI between 18.5 and 29.9 kg/m²
Able to understand the study and provide written informed consent
Considered suitable for study participation by the investigator based on medical history, physical examination, and clinical laboratory tests
Clinically significant medical or surgical history
Gastrointestinal disease or surgery affecting drug absorption
Hypersensitivity to PARP inhibitors or other significant drug allergy
Drug abuse history or positive drug screening